Disease-Specific Patient Reported Outcome Tools for Systemic Lupus Erythematosus

被引:116
|
作者
Jolly, Meenakshi [1 ]
Pickard, A. Simon [3 ]
Block, Joel A.
Kumar, Rajan B.
Mikolaitis, Rachel A.
Wilke, Caitlyn T. [2 ]
Rodby, Roger A.
Fogg, Louis
Sequeira, Winston [2 ]
Utset, Tammy O. [4 ]
Cash, Thomas F. [5 ]
Moldovan, Iona [7 ]
Katsaros, Emmanuel [7 ]
Nicassio, Perry [8 ]
Ishimori, Mariko L. [6 ]
Kosinsky, Mark [10 ]
Merrill, Joan T. [9 ]
Weisman, Michael H. [6 ]
Wallace, Daniel J. [6 ]
机构
[1] Rush Univ, Rheumatol Sect, Med Ctr, Chicago, IL 60612 USA
[2] John H Stroger Hosp, Chicago, IL USA
[3] Univ Illinois, Chicago, IL USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Old Dominion Univ, Norfolk, VA USA
[6] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[7] Loma Linda Univ, Sch Med, Loma Linda, CA USA
[8] Univ Calif Los Angeles, Los Angeles, CA USA
[9] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[10] Qual Metr Inc, Lincoln, RI USA
关键词
systemic lupus erythematosus; patient reported outcome; quality of life; health outcomes; health measurement; QUALITY-OF-LIFE; CLINICAL-TRIALS; VALIDATION; CONSENSUS; WOMEN; PREVALENCE; INSTRUMENT; DESIGN; PEOPLE; SCALE;
D O I
10.1016/j.semarthrit.2011.12.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Systemic lupus erythematosus (SLE) can significantly affect both health and non-health-related quality of life (HRQOL and non-HRQOL). However, of the existent published patient-reported outcome (PRO) tools, none were developed from US patients, an ethnically diverse population. Furthermore, these tools do not address men with SLE or assess non-HRQOL issues. Herein, we present the development and validation of the Lupus Patient-Reported Outcome tool (LupusPRO) and discuss its clinical utility and research value compared with other PRO tools currently available for SLE. Methods: Beginning with a conceptual framework, items for LupusPRO were generated using feedback from women and men with SLE. The tool underwent iterations based on patient feedback and clinimetric and psychometric analyses. Validity (content, construct, and criterion) and reliability (internal consistency and test-retest) for the 44-item LupusPRO tool are presented. Results: Consistent with the conceptual framework, items were identified that were related to HRQOL and non-HRQOL constructs. HRQOL domains induded (1) lupus symptoms; (2) physical health (physical function, role physical); (3) pain vitality, (4) emotional health (emotional function and role emotional); (5) body image; (6) cognition; (7) procreation; and (8) lupus medications. Non-HRQOL domains were (1) available social support and coping; (2) desires goals; and (3) satisfaction with medical care. Internal consistency reliability (0.68-0.94), test-retest reliability (0.55-0.92), content, construct (r>0.50 with SF-36), and criterion (r>0.35 with disease activity) validity were fair to good. Conclusions: LupusPRO is a valid and reliable disease-targeted patient-reported health outcome tool that is generalizable to SLE patients in the United States of varied ethnic backgrounds and either gender. (C) 2012 Published by Elsevier Inc. Semin Arthritis Rheum 42:56-65
引用
收藏
页码:56 / 65
页数:10
相关论文
共 50 条
  • [1] VALIDATION OF A DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE FOR ARABIC PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    El Miedany, Y.
    El Gaafary, M.
    Sayed, S.
    Ahmed, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 189 - 189
  • [2] Cross-cultural Validation of a Disease-specific Patient-reported Outcome Measure for Systemic Lupus Erythematosus in Canada
    Bourre-Tessier, Josiane
    Clarke, Ann E.
    Mikolaitis-Preuss, Rachel A.
    Kosinski, Mark
    Bernatsky, Sasha
    Block, Joel A.
    Jolly, Meenakshi
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) : 1327 - 1333
  • [3] Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus
    Azizoddin, D. R.
    Weinberg, S.
    Gandhi, N.
    Arora, S.
    Block, J. A.
    Sequeira, W.
    Jolly, M.
    LUPUS, 2018, 27 (05) : 728 - 737
  • [4] THE POLISH VALIDATION OF A DISEASE SPECIFIC PATIENT REPORTED OUTCOME MEASURE OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Saletra, A.
    Meenakshi, J.
    Fronczyk, K.
    Czuszynska, Z.
    Sierakowska, M.
    Szmyrka, M.
    Olesinska, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1849 - 1849
  • [5] Validation of the French Version of Lupus Patient Reported Outcome (LupusPRO), a Disease-Specific Patient Reported Outcome for Lupus Patients
    Devilliers, Herve
    Jolly, Meenakshi
    Samson, Maxime
    Bonnotte, Bernard
    Maurier, Francois
    Seve, Pascal
    Magy-Bertrand, Nadine
    Wahl, Denis
    Pennaforte, Jean-Loup
    Martin, Thierry
    Aumaitre, Olivier
    Blaison, Gilles
    Bielefeld, Philip
    Mathian, Alexis
    Binquet, Christine
    Amoura, Zahir
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE)
    Mosca, M.
    Bombardieri, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (06) : S107 - S113
  • [7] The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus
    Bourre-Tessier, J.
    Clarke, A. E.
    Kosinski, M.
    Mikolaitis-Preuss, R. A.
    Bernatsky, S.
    Block, J. A.
    Jolly, M.
    LUPUS, 2014, 23 (14) : 1452 - 1459
  • [8] PATIENT-REPORTED OUTCOME (PRO) ASSESSMENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Wyrwich, K.
    Winnette, R.
    Oglesby, A.
    Narayanan, S.
    VALUE IN HEALTH, 2012, 15 (07) : A515 - A515
  • [9] Validation of Lupuspro V1.8, Disease Targeted Patient Reported Outcome for Systemic Lupus Erythematosus
    Jolly, Meenakshi
    Gandhi, Nisarg
    Nevares, Alana
    Sequeira, Winston
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines
    Navarra, S. V.
    Tanangunan, R. M. D. V.
    Mikolaitis-Preuss, R. A.
    Kosinski, M.
    Block, J. A.
    Jolly, M.
    LUPUS, 2013, 22 (03) : 262 - 267